# A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

> **NCT04765553** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 8 (actual)

## Conditions studied

- Rare Diseases

## Interventions

- **DRUG:** NI-0501
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04765553
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-14
- **Primary completion:** 2021-06-25
- **Final completion:** 2021-07-25
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04765553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04765553, "A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04765553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*